Applied Genetic Technologies reported $90.52M in Cash and Equivalent for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Alimera Sciences ALIM:US $ 21.52M 3.26M
Applied Genetic Technologies AGTC:US $ 90.52M 14.54M
Avrobio Inc AVRO:US $ 201.37M 25.07M
Biogen BIIB:US $ 1541.8M 200.2M
Bluebird Bio BLUE:US $ 402.46M 48.99M
Celldex Therapeutics CLDX:US $ 72.18M 28.74M
Cti Biopharma CTIC:US $ 95.28M 23.4M
Gilead Sciences GILD:US $ 6837M 1944M
Insmed INSM:US $ 846.56M 81.77M
Intercept Pharmaceuticals ICPT:US $ 428.77M 283.15M
Life Technologies LIFE:US $ 59.74M 57.55M
Regeneron Pharmaceuticals REGN:US $ 3432.4M 1360.2M
Rigel Pharmaceuticals RIGL:US $ 30.4M 54.42M
Ultragenyx Pharmaceutical RARE:US $ 197.54M 93.34M